News

Glancy Prongay & Murray Enters Investigation for TMCI Investors

Glancy Prongay & Murray Enters Investigation for TMCI Investors

Glancy Prongay & Murray Launches Investigation into Treace Medical

Glancy Prongay & Murray LLP, a respected national law firm, has initiated an investigation on behalf of Treace Medical Concepts, Inc. (NASDAQ: TMCI) aimed at uncovering possible violations of federal securities laws. This initiative stems from recent developments that may significantly affect TMCI investors.

Impact of Recent Financial Results

On May 7, 2024, Treace Medical Concepts announced its financial results for the first quarter of 2024. In addition, the company revised its full-year guidance downward by approximately $20 million. The company indicated that this adjustment was due to increased competition and the rising usage of its MIS Osteotomy solutions, which also affected the market performance of their popular Lapiplasty products.

Stock Price Reaction

Following the release of these financial results, Treace's stock suffered a substantial blow. On May 8, 2024, the stock price plummeted by $6.95, marking a staggering decline of 62.5%, resulting in a close at $4.17 per share. This sharp drop has raised concerns among shareholders regarding the company's future and its adherence to securities regulations.

Investors Encouraged to Act

If you have experienced financial losses related to your investments in Treace Medical, Glancy Prongay & Murray encourages you to reach out to discuss potential claims to recover those losses. This is an opportunity for affected investors to assert their rights under the applicable federal securities laws.

Contact Information

For further details, investors can submit their contact information via Glancy Prongay & Murray’s official website. Additionally, for inquiries or advice, investors may contact attorney Charles H. Linehan directly at 310-201-9150 or toll-free at 888-773-9224. They can also reach out via email for more details about their rights and potential courses of action.

Whistleblower Information

Individuals with non-public information regarding Treace Medical Concepts may also consider participating in the SEC Whistleblower Program. This program entitles whistleblowers to receive rewards, possibly amounting to 30% of any recovery obtained by the SEC owing to the information provided. Contact can also be made through the provided numbers or email to learn more about this possibility.

About Glancy Prongay & Murray LLP

Glancy Prongay & Murray LLP is a premier law firm specializing in representing investors and consumers in a variety of litigation contexts, notably securities litigation and complex class action disputes. The firm has achieved significant recognition within the legal landscape, often ranked among the top firms for securities class action settlements. Their experienced team has successfully recovered billions of dollars for clients across multiple sectors, including healthcare, biotech, and technology.

With a dedication to fighting corporate misconduct, GPM’s lawyers have been involved in high-profile cases concerning securities fraud, earnings manipulation, and violations of regulatory standards. Their work has attracted considerable media coverage from prestigious publications, thus establishing their reputation as leaders in the field.

Frequently Asked Questions

What prompted Glancy Prongay & Murray to investigate Treace Medical Concepts?

The investigation was prompted by potential violations of federal securities laws following Treace's lowered financial guidance and the subsequent impact on their stock price.

What has been the impact on Treace Medical's stock price?

Following the announcement of their revised financial results, Treace Medical's stock dropped by $6.95, representing a 62.5% decline.

How can investors participate in the investigation?

Investors are encouraged to contact Glancy Prongay & Murray to discuss their rights and potential claims regarding losses incurred.

What is the SEC Whistleblower Program?

The SEC Whistleblower Program rewards individuals who provide original information about violations of securities laws, potentially entitling them to a share of any resulting recovery.

What type of cases does Glancy Prongay & Murray handle?

GPM specializes in securities litigation, class action lawsuits, and other complex legal cases, advocating for investor and consumer rights across various industries.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Medicare Competitive Bidding May Slash Jobs, Access

Updated Category News Views 5

Medicare's New Program: Potential Knockout Punch? Today, we dive into Medicare's latest shake-up that might just be the unseen wrecking ball swinging toward thousands of jobs and small businesses in the healthcare sector. Two years from now, starting January 2028, the Competitive Bidding Program is set to reroute the entire landscape for suppliers of key medical products...

Continue Reading
Red Banyan Earns Top Honors in Florida for 2026

Updated Category News Views 8

Red Banyan: A Powerhouse in Reputation Management Boy, have you ever watched a company rise through the ranks almost like a caffeine kick on a drowsy morning? That's Red Banyan for you. This outfit, right out of Fort Lauderdale, snagged the '2026 Best of Florida' award as the cream of the crop in the Business Consulting Firms category. It’s like taking home an Oscar in...

Continue Reading
ScholarShare 529 Launches $50 Back-to-School Promo

Updated Category News Views 7

California Families Get a Boost With New 529 Plan Offer Everywhere you turn, it's 'back to school' mania right now, and ScholarShare 529 aims to ride that wave by sweetening the pot for parents ready to think ahead. So here's the gist—California's official college savings plan is handing out a $50 gift card for new accounts opened between now and September 30th. Setting...

Continue Reading
Jacob Walthour to Be Honored for Economic Leadership

Updated Category News Views 8

The Honoring of Leadership That Goes Beyond Business In a world where financial influence often feels like it funnels into the same familiar pockets, the news of Jacob Walthour Jr.'s upcoming recognition feels like a fresh breeze of change. The Alpha Phi Alpha's Alpha Alpha Lambda Chapter is rolling out the red carpet at its Centennial Gala for Walthour, throwing him into...

Continue Reading
American Savings Bank IPO Hits NYSE: $129M Raised

Updated Category News Views 14

A Big Day for American Savings Bank Buckled up yet? Because American Savings Bank has just shot onto the NYSE, raising a hefty $129 million. A solid start, I’d say, for a Honolulu-based outfit that now struts around with a valuation tipping beyond $1.03 billion. That’s what you get when you price more than eight million shares at $16 a pop. NYSE:ASBH is the new kid on...

Continue Reading
Koogler's Sale to ALL4: A Game-Changer for the Southeast

Updated Category News Views 6

A Strategic Alignment Unfolds in Environmental Engineering Ever notice how those industry shifts often sneak up on you, only to leave a mark that's hard to ignore? That's exactly what's playing out with Koogler & Associates' recent hookup with ALL4 LLC. Set aside that coffee, this one's too important to miss if you've got a stake in the environmental consulting game or...

Continue Reading
B2B Growth Hinges on Narrative Coherence, Study Shows

Updated Category News Views 7

Clear Stories, Stronger Growth If companies can't tell a clear story that their buyers understand and believe, they're destined to stagnate. That's the blunt reality kompeld is pushing with their H2 2026 Narrative Coherence Benchmark. The report scores 150 B2B tech companies on their narrative coherence, showing there's a stark correlation between storytelling and growth....

Continue Reading
Ransoms and Mega-Losses Surge in Cyber Claims Study

Updated Category News Views 6

Cyber Costs Skyrocket in Latest Study NetDiligence’s 2026 Cyber Claims Study isn't just another report—it’s a wake-up call. The numbers paint a stark picture: cyber incidents are burning deeper holes in pockets, and no one's immune. Whether you're a scrappy SME or a lumbering corporate giant, this report puts a magnifying glass to the chilling reality of cyber...

Continue Reading
Finastra Recognized as 2026 Leader in Payment Platforms

Updated Category News Views 8

Finastra Steals the Spotlight in Payments Innovation When it comes to the modern world of finance, nothing screams ‘adapt or fade into oblivion’ like the payments industry. Well, here’s a reality check from QKS Group: Finastra has snatched the spotlight in their SPARK Matrix™ for 2026 as a powerhouse in integrated bank payments platforms. Clearly, this ain’t...

Continue Reading
Propensity Rockets to No. 70 on the 2026 Inc. 5000 List

Updated Category News Views 6

Hold onto your hats, folks—Propensity just blasted its way to Number 70 on the Inc. 5000 for 2026. That's quite a leap from the 2,591 spot just last year. If you're scratching your head wondering what's behind this meteoric rise, it’s all about AI and knowing which buyer signals really matter. The AI Advantage in B2B The B2B marketing space isn't exactly the new Wild...

Continue Reading

Top 5 Most Recently Viewed Articles

Uber Eats Collaborates with Spirit Halloween for Thrilling Offers

Updated Category News Views 220

Uber Eats teamed up with Spirit Halloween back in 2024, shaking things up for seasonal shoppers across North America. This partnership aimed to deliver a unique shopping experience, letting customers order costumes and spooky decorations straight through the Uber Eats app. As online shopping surged, especially during events like Halloween, this collaboration couldn’t...

Continue Reading
Electreon Collaborates with ATLoS for Wireless Charging Innovation

Updated Category News Views 181

Electreon and ATLoS Collaboration Announcement Electreon, known for its cutting-edge wireless charging technology, has embarked on an exciting journey by entering a collaboration agreement with ATLoS, a company focused on creating autonomous vehicles for industrial use. This partnership aims to revolutionize the landscape of autonomous and wireless powered industrial...

Continue Reading
Myriad Genetics Launches Innovative Prenatal Testing Website

Updated Category News Views 211

Introducing a New Resource for Prenatal Genetic Testing Myriad Genetics, Inc. (NASDAQ: MYGN), a trailblazer in genetic testing and precision medicine, has just unveiled a groundbreaking educational website that offers extensive insights into reproductive and prenatal genetic testing. This initiative responds to the growing demand for accessible information regarding...

Continue Reading
Understanding the Growing Multiple System Atrophy (MSA) Market

Updated Category News Views 170

Overview of the MSA Market Growth The Multiple System Atrophy (MSA) market is on the brink of significant expansion, projected to reach a valuation of US$ 202.3 Million by the year 2031. This growth trajectory, commencing from an estimated US$ 148.1 Million in 2024, represents a compound annual growth rate (CAGR) of 4.5% throughout the forecast period from 2024 to 2031....

Continue Reading
Investigative Alert: Is Poseida's Shareholder Deal Fair?

Updated Category News Views 102

In-Depth Analysis: Poseida Therapeutics Shareholder Investigation In a significant turn of events, Ademi LLP is embarking on an investigation concerning Poseida Therapeutics, Inc. (NASDAQ: PSTX). The focus? Examining if the company is providing a fair price and acting in the best interests of its public shareholders amidst its transaction with Roche. Understanding the...

Continue Reading